Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 2 | 2019 | 250 | 1.080 |
Why?
|
| Prodromal Symptoms | 1 | 2019 | 15 | 0.670 |
Why?
|
| Inflammation | 4 | 2019 | 1118 | 0.630 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 155 | 0.580 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 305 | 0.530 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 317 | 0.490 |
Why?
|
| Cognition | 1 | 2018 | 483 | 0.460 |
Why?
|
| Adipose Tissue | 2 | 2013 | 286 | 0.160 |
Why?
|
| Schizophrenic Psychology | 1 | 2018 | 65 | 0.150 |
Why?
|
| Interleukin-12 | 1 | 2018 | 122 | 0.150 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 396 | 0.140 |
Why?
|
| Cognition Disorders | 1 | 2018 | 232 | 0.130 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 377 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 589 | 0.130 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 313 | 0.120 |
Why?
|
| CD40 Antigens | 1 | 2013 | 61 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2013 | 97 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2011 | 61 | 0.090 |
Why?
|
| Diet | 2 | 2013 | 650 | 0.090 |
Why?
|
| Adipose Tissue, Brown | 1 | 2011 | 111 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2013 | 409 | 0.080 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2008 | 6 | 0.080 |
Why?
|
| Integrins | 1 | 2008 | 106 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2008 | 195 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 150 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2005 | 49 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2008 | 541 | 0.060 |
Why?
|
| Male | 6 | 2018 | 28501 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 333 | 0.060 |
Why?
|
| Obesity | 1 | 2013 | 1222 | 0.060 |
Why?
|
| Liver Cirrhosis | 1 | 2005 | 163 | 0.060 |
Why?
|
| Humans | 4 | 2019 | 61061 | 0.050 |
Why?
|
| Hypertension | 1 | 2008 | 616 | 0.050 |
Why?
|
| Adult | 1 | 2018 | 16253 | 0.050 |
Why?
|
| Middle Aged | 1 | 2018 | 16897 | 0.050 |
Why?
|
| Liver | 1 | 2005 | 806 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2013 | 646 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 3251 | 0.040 |
Why?
|
| Female | 2 | 2018 | 31771 | 0.040 |
Why?
|
| Disease Progression | 2 | 2013 | 1130 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2013 | 58 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2013 | 99 | 0.030 |
Why?
|
| Mice | 3 | 2013 | 10393 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 195 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 459 | 0.020 |
Why?
|
| Animals | 4 | 2013 | 19880 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 596 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 13 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 58 | 0.020 |
Why?
|
| Uncoupling Protein 1 | 1 | 2011 | 50 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 204 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 78 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 135 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2011 | 61 | 0.020 |
Why?
|
| Ion Channels | 1 | 2011 | 89 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 150 | 0.020 |
Why?
|
| Adipocytes | 1 | 2013 | 254 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 101 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2011 | 205 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 534 | 0.020 |
Why?
|
| RNA | 1 | 2013 | 405 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 861 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2008 | 62 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2008 | 132 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 2023 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 197 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 140 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 695 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2005 | 35 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 485 | 0.020 |
Why?
|
| Collagen | 1 | 2005 | 118 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 456 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 486 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 582 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 881 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 1310 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 649 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 1976 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 2522 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 1930 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 2114 | 0.010 |
Why?
|